| 영문 | five-year survival rate | 한글 | 오년생존율 |
|---|---|---|---|
| 설명 | 1. 동일 질병의 진단 혹은 치료 후, 5년이 경과 된 뒤의 생존자수의 표현. 2. 암의 진단 또는 치료 뒤에 검사를 반복하여 5년 동안 살아 있는 사람의 백분율. 치료 후 5년 동안 생존하면 일단 치유된 것으로 간주한다. |
||
| CSR | central supply room; chart-stimulated recall [test]; Cheyne-Stokes respiration; continued stay revie... |
|---|---|
| SVA | selective vagotomy and antrectomy; selective visceral angiography; sequential ventriculoatrial [paci... |
| 5 YSR | 5 Year Survival Rate |
| YSR | Year Survival Rate |
| CDS | cardiovascular surgery; catechol-3, 5-disulfonate; caudal dysplasia syndrome; Chemical Data System; ... |
| B | bias |
|---|---|
| CHESS | Chemical shift selective |
| DS | Directionally selective |
| HSV | Highly selective vagotomy |
| ISE | Ion-Selective Electrode |
| bias | <statistics> In a clinical trial, bias refers to effects that a conclusion that may be incorrect as, for example, when a researcher or patient knows what treatment is being given. To avoid bias, a blinded study may be done. Any deviation of results or inferences from the truth, or processes leading to such deviation. Bias can result from several sources: one-sided or systematic variations in measurement from the true value (systematic error); flaws in study design; deviation of inferences, interpretations, or analyses based on flawed data or data collection; etc. There is no sense of prejudice or subjectivity implied in the assessment of bias under these conditions. (27 Jun 1999) |
|---|---|
| publication bias | The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimised by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc. (12 Dec 1998) |
| selection bias | The introduction of error due to systematic differences in the characteristics between those selected and those not selected for a given study. In sampling bias, error is the result of failure to ensure that all members of the reference population have a known chance of selection in the sample. (12 Dec 1998) |
| insurance selection bias | Adverse of favourable selection bias exhibited by insurers or enrollees resulting in disproportionate enrollment of certain groups of people. (12 Dec 1998) |
| internal bias | Applied to the motile behaviour of crawling cells that, in the short term, show persistence and do not behave as true random walkers. Any intrinsic regulation of the random motile behaviour of the cell could be considered as internal bias. (18 Nov 1997) |
| median survival | <statistics> Median means the middle value. An equal number of people live longer as die earlier than the median. (16 Dec 1997) |
| cell survival | The span of viability of a cell characterised by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. (12 Dec 1998) |
| graft survival | <haematology> The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. (12 Dec 1998) |
| survival | 1. A living or continuing longer than, or beyond the existence of, another person, thing, or event; an outliving. 2. Any habit, usage, or belief, remaining from ancient times, the origin of which is often unknown, or imperfectly known. "The close bearing of the doctrine of survival on the study of manners and customs." (Tylor) Survival of the fittest. <biology> See Natural selection, under Natural. Origin: From Survive. Source: Websters Dictionary (01 Mar 1998) |
| survival analysis | A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. (12 Dec 1998) |
| survival rate | The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. (12 Dec 1998) |
| survival time | The period elapsing between the completion or institution of any procedure and death, the life-span of biologically or physically marked erythrocytes or other cells. (05 Mar 2000) |
| disease-free survival | Period after successful treatment in which there is no appearance of the symptoms or effects of the disease. (12 Dec 1998) |
| tissue survival | The span of viability of a tissue or an organ. (12 Dec 1998) |
| five year survival rate | The proportion of patients still alive five years after a diagnosis or form of treatment is completed. Usually applied to statistics of survival of cancer patients, since after five years, recurrences are much less likely to occur. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|